Safety and Clinical Performance of Peripherics Paclitaxel-Coated Balloon Catheter in Below-the-Knee Arteries: A

Prashant Sarda1, PremChand Gupta2, Pradeep Burli2

  • 1Vascular Surgery, Shri Mahant Indiresh Hospital, Dehradun, IND.

Cureus
|August 14, 2026
PubMed

Insights

The Peripherics™ paclitaxel-coated balloon (PCB) catheter shows promising safety and effectiveness for treating below-the-knee arterial disease. This study found low complication rates and significant clinical improvement in patients within 30 days.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Below-the-knee (BTK) arterial disease poses a significant risk of limb loss.
  • Evidence for routine use of paclitaxel-coated balloons (PCBs) in BTK disease is limited.
  • The Peripherics™ PCB catheter is a novel device for treating BTK lesions.

Purpose of the Study:

  • To evaluate the safety and clinical performance of the Peripherics™ PCB catheter.
  • To assess the device in routine clinical practice for BTK arterial disease.
  • To determine the rate of major adverse limb events (MALE) and perioperative death (POD) at 30 days.

Main Methods:

  • Retrospective, observational, multicenter, single-arm, post-market study.
  • Included 70 patients with Rutherford categories III-V BTK arterial disease.
  • Primary safety endpoint: 30-day MALE and POD.

Main Results:

  • 71 Peripherics™ PCB catheters used in 70 patients; high technical and procedural success rates (100% and 97.1%).
  • Mean ankle-brachial index improved significantly post-procedure.
  • Low 30-day MALE and POD rate of 2.9% (1.4% reintervention, 1.4% death).
  • 87% of patients showed clinical improvement (Rutherford class).

Conclusions:

  • The Peripherics™ PCB catheter demonstrated favorable safety and clinical outcomes.
  • Low event rates and significant clinical improvement were observed at 30 days.
  • Supports the use of Peripherics™ PCB for BTK arterial disease treatment.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...